Sumitomo Mitsui Trust Group
WST icon

Sumitomo Mitsui Trust Group’s West Pharmaceutical WST Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.3M Sell
168,080
-4,700
-3% -$1.44M 0.03% 407
2026
Q1 		$43.3M Sell
172,780
-3,336
-2% -$830K 0.03% 480
2025
Q4 		$48.5M Sell
176,116
-12,379
-7% -$3.39M 0.03% 477
2025
Q3 		$49.4M Sell
188,495
-3,148
-2% -$765K 0.03% 476
2025
Q2 		$41.9M Buy
191,643
+13,446
+8% +$2.87M 0.03% 499
2025
Q1 		$39.9M Sell
178,197
-1,172
-0.7% -$323K 0.03% 501
2024
Q4 		$58.8M Buy
179,369
+1,786
+1% +$562K 0.04% 413
2024
Q3 		$53.3M Sell
177,583
-224
-0.1% -$68.6K 0.04% 435
2024
Q2 		$58.6M Sell
177,807
-13,662
-7% -$4.83M 0.04% 393
2024
Q1 		$75.8M Buy
191,469
+2,759
+1% +$1.02M 0.05% 376
2023
Q4 		$66.4M Sell
188,710
-7,547
-4% -$2.67M 0.05% 395
2023
Q3 		$73.6M Sell
196,257
-207
-0.1% -$80.1K 0.06% 346
2023
Q2 		$75.1M Sell
196,464
-27,302
-12% -$9.75M 0.06% 358
2023
Q1 		$77.5M Sell
223,766
-71,807
-24% -$21M 0.06% 365
2022
Q4 		$69.6M Sell
295,573
-87,770
-23% -$20.8M 0.06% 397
2022
Q3 		$94.3M Sell
383,343
-62,313
-14% -$19M 0.08% 304
2022
Q2 		$135M Buy
445,656
+9,804
+2% +$3.19M 0.1% 224
2022
Q1 		$179M Sell
435,852
-64,154
-13% -$25.1M 0.12% 185
2021
Q4 		$235M Sell
500,006
-4,275
-0.8% -$1.84M 0.14% 159
2021
Q3 		$214M Sell
504,281
-12,490
-2% -$5.27M 0.13% 169
2021
Q2 		$186M Sell
516,771
-8,599
-2% -$2.84M 0.11% 210
2021
Q1 		$148M Sell
525,370
-1,313
-0.2% -$376K 0.09% 240
2020
Q4 		$149M Buy
526,683
+8,961
+2% +$2.51M 0.1% 230
2020
Q3 		$142M Buy
517,722
+98,139
+23% +$26M 0.1% 226
2020
Q2 		$95.3M Buy
419,583
+55,277
+15% +$10.9M 0.07% 313
2020
Q1 		$55.5M Buy
364,306
+111,000
+44% +$17.1M 0.05% 411
2019
Q4 		$38M Buy
+253,306
New +$36.9M 0.03% 554

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sumitomo Mitsui Trust Group's WST Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its West Pharmaceutical (WST) stake by 2.7% in Q2 2026, selling an estimated $1.44M and leaving 168,080 shares worth $60.3M. The position accounts for 0.03% of the portfolio, ranked #407.

Sumitomo Mitsui Trust Group first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $235M in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 168,080 shares of West Pharmaceutical worth $60.3M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 4,700 West Pharmaceutical shares in Q2 2026, an estimated $1.44M.
  • West Pharmaceutical made up 0.03% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #407 holding.
  • Sumitomo Mitsui Trust Group first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • Sumitomo Mitsui Trust Group's West Pharmaceutical position peaked at $235M in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.